Jim Cramer's Top Stock Picks: WMB AA BIIB REGN CELG GILD UNUM

Search Jim Cramer's "Mad Money" trading recommendations using our exclusive "Mad Money" Stock Screener.


NEW YORK (TheStreet) -- Here are some of the hot stocks Jim Cramer talked about on Tuesday's Mad Money on CNBC:

WMB Chart
WMB
data by YCharts

Williams Companies (WMB): Investors looking for a bargain should look no further than this top performer from last quarter, Cramer told viewers.

AA Chart
AA
data by YCharts

Alcoa (AA): Cramer said this aluminum maker continues to reinvent itself and its transformation is far from over.

CELG Chart
CELG
data by YCharts

Biogen Idec (BIIB), Regeneron (REGN), Celgene (CELG) and Gilead Sciences (GILD): Cramer said these "four horsemen of biotech" are still roaring higher and the technical analysis agrees.

UNM Chart
UNM
data by YCharts

Unum Group (UNM): Some companies are just slow and steady growers, Cramer told viewers, and Unum fits that bill perfectly.

To read a full recap of "Mad Money" on CNBC, click here.

To watch replays of Cramer's video segments, visit the Mad Money page on CNBC.

To sign up for Jim Cramer's free Booyah! newsletter with all of his latest articles and videos please click here.

-- Written by Scott Rutt in Washington, D.C.

To email Scott about this article, click here: Scott Rutt

Follow Scott on Twitter @ScottRutt or get updates on Facebook, ScottRuttDC
At the time of publication, Cramer's Action Alerts PLUS had no position in stocks mentioned.

If you liked this article you might like

Will Inflation Set Stocks' Hearts Aflutter or Be a Poison Arrow? -- Market Recon

Will Inflation Set Stocks' Hearts Aflutter or Be a Poison Arrow? -- Market Recon

Energize Your Portfolio With 12 Stock Picks in Oil, Gas and Drilling Services

Energize Your Portfolio With 12 Stock Picks in Oil, Gas and Drilling Services

Williams Cos. Train Is Leaving the Station

Williams Cos. Train Is Leaving the Station

Jim Cramer: How to Play the Energy Sector in 2018

Jim Cramer: How to Play the Energy Sector in 2018

Why Some Think It's 'Prime Time' for Amazon to Enter the Pharmacy Market

Why Some Think It's 'Prime Time' for Amazon to Enter the Pharmacy Market